Skip to main content
Livermore
Livermore
ZHEN

Ancora Advisors, LLC

SEC CIK
0001446114
Latest filing
Aug 14, 2026

LGNDZ holding history

Ligand Pharmaceuticals Inc in every 13F filed by Ancora Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LGNDZ overviewAll 13F holders of LGNDZFull Q2 2026 holdings

Shares (Q2 2026)
12,000
Value
$16
% of portfolio
<0.1%
Quarters held
17
Since Q1 2021
Holdings of LGNDZ by Ancora Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202612,000$16<0.1%00.0%UnchangedHolders
Q1 202612,000$16<0.1%00.0%UnchangedHolders
Q4 202512,000$82<0.1%00.0%UnchangedHolders
Q3 202512,000$84<0.1%00.0%UnchangedHolders
Q2 202512,000$30<0.1%+12,000NewHolders
Q1 20250$00.0%−12,000−100.0%Sold outHolders
Q4 202412,000$28<0.1%00.0%UnchangedHolders
Q3 202412,000$24<0.1%00.0%UnchangedHolders
Q2 202412,000$42<0.1%+12,000NewHolders
Q1 20240$00.0%−12,000−100.0%Sold outHolders
Q4 202312,000$54<0.1%+12,000NewHolders
Q3 20230$00.0%−12,000−100.0%Sold outHolders
Q2 202312,000$11<0.1%00.0%UnchangedHolders
Q1 202312,000$60<0.1%00.0%UnchangedHolders
Q4 202212,000$00.0%00.0%UnchangedHolders
Q3 202212,000$00.0%00.0%UnchangedHolders
Q2 202212,000$00.0%+12,000NewHolders
Q1 20220$00.0%−12,000−100.0%Sold outHolders
Q4 202112,000$00.0%+12,000NewHolders
Q3 20210$00.0%−12,000−100.0%Sold outHolders
Q2 202112,000$00.0%00.0%UnchangedHolders
Q1 202112,000$00.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.